14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $4.73 $10.53 Thursday, 2nd May 2024 IBRX stock ended at $8.97. This is 5.04% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.55% from a day low at $8.25 to a day high of $9.12.
90 days $3.37 $10.53
52 weeks $1.25 $10.53

Historical ImmunityBio, Inc. prices

Date Open High Low Close Volume
May 02, 2024 $8.72 $9.12 $8.25 $8.97 8 482 269
May 01, 2024 $7.94 $8.99 $7.45 $8.54 12 673 212
Apr 30, 2024 $8.87 $9.39 $7.90 $7.99 14 652 511
Apr 29, 2024 $8.41 $10.53 $8.12 $8.99 65 855 519
Apr 26, 2024 $5.11 $7.74 $4.92 $7.35 39 079 607
Apr 25, 2024 $5.06 $5.18 $4.82 $5.11 8 365 931
Apr 24, 2024 $5.43 $5.72 $4.79 $4.82 7 848 278
Apr 23, 2024 $6.16 $6.19 $4.84 $5.49 30 579 691
Apr 22, 2024 $5.27 $5.35 $4.92 $4.94 4 225 838
Apr 19, 2024 $4.91 $5.31 $4.82 $5.27 4 554 972
Apr 18, 2024 $5.09 $5.28 $4.91 $4.91 3 504 418
Apr 17, 2024 $5.09 $5.43 $4.77 $5.24 4 281 825
Apr 16, 2024 $5.12 $5.12 $4.85 $4.92 2 857 108
Apr 15, 2024 $5.15 $5.55 $4.93 $5.24 3 830 049
Apr 12, 2024 $6.05 $6.09 $4.73 $5.11 6 858 127
Apr 11, 2024 $6.01 $6.26 $5.96 $6.06 3 346 458
Apr 10, 2024 $5.99 $6.13 $5.73 $5.96 4 351 150
Apr 09, 2024 $6.20 $6.33 $5.98 $6.16 3 392 168
Apr 08, 2024 $5.75 $6.18 $5.59 $6.17 3 195 547
Apr 05, 2024 $5.62 $5.86 $5.48 $5.71 3 262 374
Apr 04, 2024 $5.74 $5.99 $5.47 $5.62 3 678 911
Apr 03, 2024 $5.22 $5.88 $5.11 $5.71 4 113 863
Apr 02, 2024 $5.22 $5.52 $5.09 $5.27 3 126 928
Apr 01, 2024 $5.35 $5.51 $4.89 $5.32 4 686 251
Mar 28, 2024 $5.41 $5.82 $5.35 $5.37 4 621 895
Click to get the best stock tips daily for free!

About ImmunityBio, Inc.

ImmunityBio. ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of... IBRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT